ctrl K

Nuvectis Pharma Inc. (NVCT)

NASDAQ: NVCT · Real-Time Price · USD

9.17

-0.45 (-4.68%)

At close: May 02, 2025, 3:59 PM

9.40

2.51%

After-hours: May 02, 2025, 05:05 PM EDT

Nuvectis Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	149K	n/a	n/a
Cost of Revenue	n/a	22.9M	19.23M	12.89M	n/a
Gross Profit	n/a	-22.9M	-19.09M	-12.89M	n/a
Operating Income	-19.85M	-22.9M	-19.23M	-12.89M	-10K
Interest Income	n/a	637K	149K	4K	n/a
Pretax Income	-19M	-22.26M	-19.09M	-12.89M	-10K
Net Income	-19M	-22.26M	-18.79M	-12.89M	-10K
Selling & General & Admin	6.93M	7.52M	6.01M	3.35M	10K
Research & Development	12.92M	15.38M	13.23M	9.54M	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	19.85M	22.9M	19.23M	12.89M	10K
Interest Expense	n/a	n/a	149K	n/a	n/a
Selling & Marketing Expenses	n/a	14K	n/a	n/a	9.98K
Cost & Expenses	n/a	22.9M	19.23M	12.89M	10K
Income Tax Expense	n/a	n/a	-298K	-4K	-24
Shares Outstanding (Basic)	17.11M	15.56M	12.66M	12.72M	12.72M
Shares Outstanding (Diluted)	17.11M	15.56M	12.66M	12.72M	12.72M
EPS (Basic)	-1.11	-1.43	-1.48	-1.01	-0.00
EPS (Diluted)	-1.11	-1.43	-1.48	-1.01	-0.00
EBITDA	-19M	-22.9M	-19.23M	-12.89M	n/a
EBIT	n/a	-21.9M	-19.09M	-12.89M	-24K
Depreciation & Amortization	n/a	-1M	-1.2M	-7.1M	24K